Signal active
Investment Firm
Overview
Oncology Pharma engages in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
Highlights
1993
Medical
1-10
1
1
undefined
N/A
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
Oncology Pharma, established in 1993 and headquartered in United States, North America., specializes in investments across Biotechnology, Medical. Their recent investments include Diagnomics. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
1
0
1
undefined
Investments
1
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Dec 11, 2019 | Diagnomics | Biotechnology | null |
Exits
0
Funding Timeline
1
1
0
Funding Rounds
1
Oncology Pharma has raised 1 rounds. Their latest funding was raised on Dec 11, 2019 from a Corporate Round - Diagnomics round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Dec 11, 2019 | Corporate Round - Diagnomics | - | 0 | - |
Investors
1
Oncology Pharma is funded by 1 investor(s). SCP Partners Kantor is the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
SCP Partners | Yes | Post-IPO Debt - Oncology Pharma | 38.4M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.